This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Mesoblast International Sarl. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Alicia Mildred Tyrell: Innovator in Stem Cell Research
Introduction
Alicia Mildred Tyrell is an influential inventor based in Catonsville, Maryland, known for her groundbreaking work in the field of stem cell research. With a strong focus on innovative solutions for medical challenges, she has contributed significantly to scientific advancements, particularly in addressing issues such as graft-versus-host disease.
Latest Patents
Alicia Tyrell holds one patent: "Mesenchymal Stem Cells Expressing TNF-α Receptors." This invention involves mesenchymal stem cells that express TNF-α receptor Type I in an amount of at least 13 pg/10 cells. These specialized cells inhibit the proliferation of lymphocytes, providing a potential therapeutic avenue for the treatment of graft-versus-host disease, a serious condition that can arise after transplantation.
Career Highlights
Tyrell's professional journey has been marked by her association with Mesoblast International Sàrl, a company dedicated to pioneering advances in cell therapies. Her work has not only added to the academic and practical understanding of mesenchymal stem cells but has also opened new pathways for clinical applications.
Collaborations
Throughout her career, Alicia has collaborated with prominent figures in her field, including Alla Danilkovitch and Diane Carter. These collaborations have fostered a dynamic research environment, enhancing the development of innovative stem cell therapies and solidifying her impact in the scientific community.
Conclusion
Alicia Mildred Tyrell's contributions to stem cell research exemplify the power of innovation in addressing complex medical challenges. Her invention of mesenchymal stem cells expressing TNF-α receptors stands as a testament to her dedication and expertise. As the field of regenerative medicine continues to evolve, inventors like Tyrell play a critical role in shaping the future of healthcare.